In addition, migration-inducting gene 7 (Mig-7), which is involved in VM by carcinoma cells, but not expressed in normal cells, may be a promising target in VM channels [302], and Mig-7-inhibitory agents together with anti–angiogenic or other conventional anti-cancer drugs might act synergistically [301,302]. Here, BCAR3 is linked to cancer.